echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > ALS patient tweets through brain-computer interface for the first time

    ALS patient tweets through brain-computer interface for the first time

    • Last Update: 2022-02-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    Australian 62-year-old amyotrophic lateral sclerosis (ALS) patient Philip O'Keefe recently became the first person to post a message on social media using only his own thoughts

    O'Keefe's technology for sending messages was developed by the brain-computer interface company Synchron, and the device is called the Stentrode brain-computer interface (SBCI): an intravascular brain implant

    This tiny (8mm) brain implant is designed to allow people who have lost the ability to speak to communicate using only their thoughts

    Like other ALS patients, O'Keefe developed progressive paralysis that left him unable to speak earlier this year

    O'Keefe used the account of Synchron CEO Thomas Oakley to tweet his history-making news

    O'Keefe expressed hope that the SBCI program in which he is a part will help pave the way for new technologies to regain independence for those who have lost the ability to speak or move

    Synchron said it plans to expand SBCI to include developing devices that can be used to diagnose and even treat conditions such as Parkinson's, high blood pressure, epilepsy and even depression



    The concept of brain-computer interface has existed for a long time, but it was not until the 1990s that there were phased results

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.